98%
921
2 minutes
20
Infants are exposed to per- and polyfluoroalkyl substances (PFAS) via feeding, yet the influence of PFAS on their gut microbiota remains poorly understood. In this study, 73 mother-preterm infant dyads were recruited in Shenzhen. We measured concentrations of 13 PFAS (PFBA, PFPeA, PFHxA, PFHpA, PFOA, PFNA, PFBS, PFHxS, PFOS, HFPO-DA, ADONA, 6:2 Cl-PFESA, and 8:2 Cl-PFESA) in the feeding substances (breast milk or formula) at the fourth week postpartum. Concurrently, fecal samples from preterm infants were collected for analysis of gut microbiota and metabolites. The highest mean concentrations were observed for two short-chain PFAS: PFBA and PFPeA. Eleven out of the 13 PFAS had detection rates exceeding 50 % and were included in subsequent analyses. Linear regression analysis indicated that daily intakes of PFBA, PFPeA, PFHxA, PFHpA, PFOA, PFNA, PFBS, and PFHxS were negatively associated with the ln-transformed PD_whole_tree index. Daily intakes of PFBA, PFBS, PFOA, and PFHxS were significantly linked with β diversity. The genus Veillonella was more abundant in the upper tertile groups of PFBA and PFBS. Moreover, daily intakes of PFHpA and PFOA were linked to predicted microbiome functions. Pathway analysis further revealed that PFAS daily intake was associated with synthesis or metabolism of multiple nutrients (including vitamins and amino acids). Notably, linear regression demonstrated that PFAS daily intake was negatively associated with levels of docosapentaenoic acid and docosahexaenoic acid. Our findings suggest that PFAS exposure through feeding may adversely affect the gut microbiota and normal development of preterm infants, potentially posing health risks.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ecoenv.2025.118853 | DOI Listing |
Front Immunol
September 2025
Department of Biomedical Sciences, College of Health Sciences, QU Health, Qatar University, Doha, Qatar.
Cancer is a multifaceted disease driven by a complex interplay of genetic predisposition, environmental factors and lifestyle habits. With the accelerating pace of cancer research, the gut microbiome has emerged as a critical modulator of human health and immunity. Disruption in the gut microbial populations and diversity, known as dysbiosis, has been linked with the development of chronic inflammation, oncogenesis, angiogenesis and metastasis.
View Article and Find Full Text PDFFront Immunol
September 2025
Guangxi Key Laboratory of AIDS Prevention and Treatment & School of Public Health, Guangxi Medical University, Nanning, Guangxi, China.
Background: People living with HIV(PLWH) are a high-risk population for cancer. We conducted a pioneering study on the gut microbiota of PLWH with various types of cancer, revealing key microbiota.
Methods: We collected stool samples from 54 PLWH who have cancer (PLWH-C), including Kaposi's sarcoma (KS, n=7), lymphoma (L, n=22), lung cancer (LC, n=12), and colorectal cancer (CRC, n=13), 55 PLWH who do not have cancer (PLWH-NC), and 49 people living without HIV (Ctrl).
Front Immunol
September 2025
Clinical Nutrition and Dietetics Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
In the last decades, immunotherapy has revolutionized cancer treatment. Despite its success, a significant number of patients fail to respond, and the underlying causes of ineffectiveness remain poorly understood. Factors such as nutritional status and body composition are emerging as key predictors of immunotherapy outcomes.
View Article and Find Full Text PDFNat Sci Sleep
September 2025
Department of Respiratory Medicine, Beijing Friendship Hospital, Capital Medical University, Beijing, People's Republic of China.
Background: Recent research has increasingly underscored a significant correlation between gut microbiota and obstructive sleep apnea (OSA). Probiotics have emerged as promising adjunctive interventions for OSA. Metabolites and their related biochemical pathways have emerged as important contributors to the development of OSA.
View Article and Find Full Text PDFFront Nutr
August 2025
Emergency Department, The Second Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guiyang City, Guizhou Province, China.
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a rising health issue linked to poor diet and gut microbiota dysbiosis. The Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet, high in polyphenols and anti-inflammatory nutrients, may help protect against MASLD. This study examined how adherence to the MIND diet relates to MASLD severity, focusing on hepatic steatosis, fibrosis, insulin resistance, inflammation, and gut microbiota diversity.
View Article and Find Full Text PDF